ICM
GS icon

Invenomic Capital Management’s Goldman Sachs GS Stock Holding History

Invenomic Capital Management’s Portfolio GS Stock Details GS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,573
Closed -$1.21M – 134
2020
Q4 		$1.21M Sell
4,573
-2,592
-36% -$577K 0.31% 66
2020
Q3 		$1.44M Sell
7,165
-763
-10% -$155K 0.79% 43
2020
Q2 		$1.57M Hold
7,928
– – 1.16% 28
2020
Q1 		$1.23M Sell
7,928
-5,369
-40% -$1.14M 1% 34
2019
Q4 		$3.06M Buy
+13,297
New +$2.89M 1.23% 32

Other funds holding GS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invenomic Capital Management's GS Position: Q1 2021 in Review

Invenomic Capital Management sold out of Goldman Sachs (GS) in Q1 2021, closing a stake of 4,573 shares — an estimated $1.21M sold.

Invenomic Capital Management first reported a position in GS in Q4 2019 and held it in 5 quarters. The position peaked at $3.06M in Q4 2019. 1,654 funds tracked by Wall St. Rank hold GS as of Q1 2021.

  • Invenomic Capital Management reported no remaining Goldman Sachs position as of Q1 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 4,573 Goldman Sachs shares in Q1 2021, an estimated $1.21M.
  • Invenomic Capital Management first reported a position in Goldman Sachs in Q4 2019 and held it in 5 quarters.
  • Invenomic Capital Management's Goldman Sachs position peaked at $3.06M in Q4 2019.
  • 1,654 funds tracked by Wall St. Rank held Goldman Sachs as of Q1 2021.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.